← Back to Patent Explorer
US4165380A Expired / Lapsed US ⏱️ 0.0 years remaining

Bis(sulfide)gold(1+) salts

Assignee: GlaxoSmithKline LLC
•
Filing: 1978-06-02
•
Granted: 1979-08-21
•
Expires: 1998-06-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The compounds are bis(sulfide)gold(1+) salts which have antiarthritic activity.

Inventors

  • 👤 David T. Hill

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 13:44
CPC Classifications
C; C07; C07F; C07F1/00; C07F1/005

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 22 words
A compound of the formula: ##STR3## in which R 1 and R 2 are 2-hydroxyethyl and X is a weakly nucleophilic anion.
Claim 2
Dependent Claim 22 words
A compound of the formula: ##STR3## in which R 1 and R 2 are 2-hydroxyethyl and X is a weakly nucleophilic anion.
Claim 3
Dependent Claim 14 words
A compound of claim 1 in which X is perchlorate, iodate, tetrafluoroborate or hexafluorophosphate.
Claim 4
Dependent Claim 28 words
A pharmaceutical composition having antiarthritic activity, in dosage unit form, comprising a pharmaceutical carrier and in an amount sufficient to produce antiarthritic activity a compound of claim 1.
Claim 5
Dependent Claim 26 words
A method of producing antiarthritic activity which comprises administering internally to an animal in an amount sufficient to produce antiarthritic activity a compound of claim 1.

References Cited (Backward Citations)

US3438748A Cited
US3635945A Cited
US3661959A Cited
US3676554A Cited
US3718679A Cited
US3718680A Cited
US3842107A Cited
US3842108A Cited
US3883546A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-08-20 1983-02-19 1983-08-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-08-20 1987-02-19 1987-08-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-08-20 1991-02-19 1991-08-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag